ANVISA registration 80003610614Active3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMGCR or HMG-CoA REDUCTASE)
ANVISA Registration Number: 80003610614WERFEN MEDICAL LTDAINOVA DIAGNOSTICS, INCRisk Class II
Device names
- Technical name
- 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMGCR or HMG-CoA REDUCTASE)
- Risk class
- Class II
PT: 3-HIDROXI-3-METILGLUTARIL-COENZIMA A REDUTASE (HMGCR ou HMG-CoA REDUTASE)
Registration details
- Registration Number
- 80003610614
- Process Number
- 25351462167202497
- CNPJ
- 02004662000165
Company information
- Registration Holder
- WERFEN MEDICAL LTDA
- Manufacturer
- INOVA DIAGNOSTICS, INC
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Feb 17, 2025
- Validity
- VIGENTE
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE (HMGCR or HMG-CoA REDUCTASE) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80003610614 and manufactured by INOVA DIAGNOSTICS, INC. The registration is held by WERFEN MEDICAL LTDA with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.